{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:33:55Z","timestamp":1793057635840,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Estimating the true burden of SARS-CoV-2 infection has been difficult in sub-Saharan Africa owing to asymptomatic infections and inadequate testing capacity. Antibody responses from serologic surveys can provide an estimate of SARS-CoV-2 exposure at the population level.<\/jats:p><\/jats:sec>Objective<\/jats:title>To estimate SARS-CoV-2 seroprevalence, attack rates, and reinfection in eastern Uganda using serologic surveillance from 2020 to early 2022.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study was conducted in the Tororo and Busia districts of eastern Uganda. Plasma samples from participants in the Program for Resistance, Immunology, Surveillance, and Modeling of Malaria in Uganda Border Cohort were obtained at 4 sampling intervals: October to November 2020, March to April 2021, August to September 2021, and February to March 2022. Each participant contributed up to 4 time points for SARS-CoV-2 serology, with almost half of all participants contributing at all 4 time points, and almost 90% contributing at 3 or 4 time points. Information on SARS-CoV-2 vaccination status was collected from participants, with the earliest reported vaccinations in the cohort occurring in May 2021.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcomes of this study were antibody responses to the SARS-CoV-2 spike protein as measured with a bead-based serologic assay. Individual-level outcomes were aggregated to population-level SARS-CoV-2 seroprevalence, attack rates, and boosting rates. Estimates were weighted by the local age distribution according to census data.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 1483 samples from 441 participants living in 76 households were tested. Of the 441 participants, 245 (55.6%) were female, and their mean (SD) age was 16.04 (16.04) years. By the end of the Delta wave and before widespread vaccination, adjusted SARS-CoV-2 seroprevalence was 67.7% (95% credible interval [CrI], 62.5%-72.6%) in the study population. During the subsequent Omicron wave, 84.8% (95% CrI, 67.9%-93.7%) of unvaccinated, previously seronegative individuals were infected for the first time, and 50.8% (95% CrI, 40.6%-59.7%) of unvaccinated, already seropositive individuals were likely reinfected, leading to an overall seropositivity of 96.0% (95% CrI, 93.4%-97.9%) in this population. These results suggest a lower probability of reinfection in individuals with higher preexisting antibody levels. There was evidence of household clustering of SARS-CoV-2 seroconversion. No significant associations were found between SARS-CoV-2 seroconversion and gender, household size, or recent Plasmodium falciparum<\/jats:italic> malaria exposure.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort study in a rural population in eastern Uganda, there was evidence of very high SARS-CoV-2 infection rates throughout the pandemic inconsistent with national level case data and high reinfection rates during the Omicron wave.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.55978","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T16:03:29Z","timestamp":1676477009000},"page":"e2255978","source":"Crossref","is-referenced-by-count":25,"title":["Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022"],"prefix":"10.1001","volume":"6","author":[{"given":"Jessica","family":"Briggs","sequence":"first","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patience","family":"Nayebare","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Cuu","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rek","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maato","family":"Zedi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kizza","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Arinaitwe","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaniter I.","family":"Nankabirwa","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"},{"name":"Department of Medicine, Makerere University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Kamya","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"},{"name":"Department of Medicine, Makerere University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna","family":"Jagannathan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Stanford, California"},{"name":"Department of Microbiology and Immunology, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Dorsey","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Greenhouse","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Ssewanyana","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration, Kampala, Uganda"},{"name":"Central Public Health Laboratories, Butabika, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rodr\u00edguez-Barraquer","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"issue":"4","key":"zoi221593r1","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/S1473-3099(20)30631-9","article-title":"SeroTracker: a global SARS-CoV-2 seroprevalence dashboard.","volume":"21","author":"Arora","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"zoi221593r2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-008793","article-title":"SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021.","volume":"7","author":"Lewis","year":"2022","journal-title":"BMJ Global Health"},{"key":"zoi221593r4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279464","article-title":"Measures of malaria transmission, infection, and disease in an area bordering two districts with and without sustained indoor residual spraying of insecticide in Uganda.","author":"Nankabirwa","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"zoi221593r5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40249-016-0164-3","article-title":"Why is malaria associated with poverty? findings from a cohort study in rural Uganda.","volume":"5","author":"Tusting","year":"2016","journal-title":"Infect Dis Poverty"},{"issue":"3","key":"zoi221593r6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.4269\/ajtmh.15-0554","article-title":"Measuring socioeconomic inequalities in relation to malaria risk: a comparison of metrics in rural Uganda.","volume":"94","author":"Tusting","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"31","key":"zoi221593r8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh3409","article-title":"SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.","volume":"7","author":"Peluso","year":"2021","journal-title":"Sci Adv"},{"issue":"1","key":"zoi221593r9","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1038\/s41467-021-23651-6","article-title":"Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records.","volume":"12","author":"Routledge","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"zoi221593r11","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.4269\/ajtmh.20-0250","article-title":"Malaria transmission, infection, and disease following sustained indoor residual spraying of insecticide in Tororo, Uganda.","volume":"103","author":"Nankabirwa","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"zoi221593r12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ijid.2020.10.104","article-title":"High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa.","volume":"102","author":"Tso","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"5","key":"zoi221593r14","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/rssc.v69.5","article-title":"Bayesian analysis of tests with unknown specificity and sensitivity.","volume":"69","author":"Gelman","year":"2020","journal-title":"J R Stat Soc Ser C Appl Stat"},{"issue":"3","key":"zoi221593r20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001788","article-title":"Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets.","volume":"12","author":"Hofmann","year":"2015","journal-title":"PLoS Med"},{"issue":"3","key":"zoi221593r21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/biomet\/80.3.517","article-title":"Modelling multivariate binary data with alternating logistic regressions.","volume":"80","author":"Carey","year":"1993","journal-title":"Biometrika"},{"issue":"6-8","key":"zoi221593r22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3109\/10826080009148432","article-title":"Use of alternating logistic regression in studies of drug-use clustering.","volume":"35","author":"Bobashev","year":"2000","journal-title":"Subst Use Misuse"},{"issue":"6","key":"zoi221593r23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.4269\/ajtmh.2009.08-0594","article-title":"Seroprevalence of Trypanosoma cruzi in rural Ecuador and clustering of seropositivity within households.","volume":"81","author":"Black","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"zoi221593r26","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1093\/cid\/ciab100","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) setting-specific transmission rates: a systematic review and meta-analysis.","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"zoi221593r27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(22)00362-0","article-title":"Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection.","volume":"22","author":"Blom","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"6603","key":"zoi221593r28","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq1841","article-title":"Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.","volume":"377","author":"Reynolds","year":"2022","journal-title":"Science"},{"key":"zoi221593r29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.565625","article-title":"Less severe cases of COVID-19 in sub-Saharan Africa: could co-infection or a recent history of Plasmodium falciparum infection be protective?","volume":"12","author":"Kalungi","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"zoi221593r30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12879-022-07064-4","article-title":"Low incidence of COVID-19 case severity and mortality in Africa: could malaria co-infection provide the missing link?","volume":"22","author":"Osei","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"1","key":"zoi221593r31","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/S2666-5247(21)00240-8","article-title":"Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda.","volume":"3","author":"Achan","year":"2022","journal-title":"Lancet Microbe"},{"issue":"31","key":"zoi221593r32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200592119","article-title":"Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.","volume":"119","author":"Syed","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"zoi221593r33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2022.01.019","article-title":"Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.","volume":"185","author":"Cui","year":"2022","journal-title":"Cell"},{"key":"zoi221593r34","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02129-22","article-title":"Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variant.","author":"Springer","year":"2022","journal-title":"Microbiol Spectrum"},{"key":"zoi221593r3","doi-asserted-by":"crossref","unstructured":"Emily? AB, Barekye? B, Bower? H, . Population-based serosurveys for SARS-CoV-2: key findings from five African countries: November 2020 to June 2021. SSRN. Preprint posted online February 22, 2022. doi:10.2139\/ssrn.4040702","DOI":"10.2139\/ssrn.4040702"},{"key":"zoi221593r7","unstructured":"Our World in Data. Uganda: coronavirus pandemic country profile. Accessed January 18, 2023. https:\/\/ourworldindata.org\/coronavirus\/country\/uganda"},{"key":"zoi221593r10","unstructured":"Github. Flexfit: flexible format standard curve fitting and data processing (R Package). Accessed July 31, 2022. https:\/\/github.com\/EPPIcenter\/flexfit"},{"key":"zoi221593r13","doi-asserted-by":"crossref","unstructured":"Mwakibete? L, Takahashi? S, Ahyong? V, . Metagenomic next-generation sequencing to characterize etiologies of non-malarial fever in a cohort living in a high malaria burden area of Uganda.? MedRxiv. Preprint posted online September 4, 2022. doi:10.1101\/2022.09.02.22279519","DOI":"10.1101\/2022.09.02.22279519"},{"key":"zoi221593r15","unstructured":"Uganda Bureau of Statistics. Eastern region: parish level profiles\u2014census 2014. January 23, 2018. Accessed January 10, 2023. https:\/\/www.ubos.org\/explore-statistics\/"},{"key":"zoi221593r16","unstructured":"Centers for Disease Control and Prevention. Current trends: serologic diagnosis of measles. July 30, 1982. Accessed August 17, 2022. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00001218.htm"},{"key":"zoi221593r17","unstructured":"Centers for Disease Control and Prevention. Serologic tests for Dengue virus. August 21, 2019. Accessed August 17, 2022. https:\/\/www.cdc.gov\/dengue\/healthcare-providers\/testing\/serologic-tests.html"},{"key":"zoi221593r18","unstructured":"Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases: chapter 6, influenza. April 6, 2022. Accessed August 17, 2022. https:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt06-influenza.html"},{"key":"zoi221593r19","unstructured":"Comprehensive R Archive Network (CRAN). Generalized estimating equation package: R package Geepack version 1.3.4. 2022. Accessed August 15, 2022. https:\/\/cran.r-project.org\/web\/packages\/geepack\/index.html"},{"key":"zoi221593r24","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2021. Accessed January 10, 2023. https:\/\/www.r-project.org\/"},{"key":"zoi221593r25","unstructured":"The Stan Development Team. Stan. Accessed November 30, 2022. https:\/\/mc-stan.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2801463\/briggs_2023_oi_221593_1675716046.24278.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T16:03:36Z","timestamp":1676477016000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2801463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55978","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}